Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 780 | 1,573 | 2,199 | 1,964 | 2,295 |
| Operating Income | -780 | -1,573 | -2,199 | -1,964 | -2,295 |
| Interest Expense | 42 | 49 | 33 | 31 | 129 |
| Other Income | 11 | -68 | -785 | -88 | 115 |
| Pre-tax Income | -811 | -1,690 | -3,017 | -2,083 | -2,309 |
| Income Tax | N/A | N/A | N/A | 1 | 24 |
| Net Income Continuous | -811 | -1,690 | -3,017 | -2,084 | -2,333 |
| Minority Interests | -74 | -130 | -250 | -41 | -76 |
| Net Income | $-737 | $-1,560 | $-2,767 | $-2,043 | $-2,257 |
| EPS Basic Total Ops | -0.03 | -0.06 | -0.11 | -0.09 | -0.13 |
| EPS Basic Continuous Ops | -0.03 | -0.07 | -0.13 | -0.09 | -0.13 |
| EPS Diluted Total Ops | -0.03 | -0.06 | -0.11 | -0.09 | -0.13 |
| EPS Diluted Continuous Ops | -0.03 | -0.07 | -0.13 | -0.09 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.06 | -0.12 | -0.05 | -0.13 |
| EBITDA(a) | $-690 | $-1,480 | $-1,985 | $-1,868 | $-2,214 |